Start Date
May 31, 1997
Primary Completion Date
March 31, 2000
Study Completion Date
March 31, 2000
Hydroxyurea
Nelfinavir mesylate
Stavudine
Didanosine
Univ of California at San Francisco Gen Hosp, San Francisco
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY